UBS AM’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.25M Buy
581,787
+84,336
+17% +$616K ﹤0.01% 1788
2025
Q1
$4.72M Sell
497,451
-148,660
-23% -$1.41M ﹤0.01% 1606
2024
Q4
$10.6M Buy
646,111
+42,895
+7% +$707K ﹤0.01% 1222
2024
Q3
$8.9M Sell
603,216
-23,239
-4% -$343K ﹤0.01% 1287
2024
Q2
$8.69M Buy
626,455
+205,436
+49% +$2.85M ﹤0.01% 1198
2024
Q1
$6.62M Buy
421,019
+17,267
+4% +$271K ﹤0.01% 1147
2023
Q4
$6.53M Sell
403,752
-13,734
-3% -$222K ﹤0.01% 1143
2023
Q3
$5.14M Buy
417,486
+22,021
+6% +$271K ﹤0.01% 1192
2023
Q2
$6.89M Hold
395,465
﹤0.01% 1099
2023
Q1
$6.89M Buy
+395,465
New +$6.89M ﹤0.01% 1099
2022
Q4
Sell
-377,967
Closed -$3.25M 2694
2022
Q3
$3.25M Sell
377,967
-33,206
-8% -$286K ﹤0.01% 1353
2022
Q2
$3.35M Sell
411,173
-13,249
-3% -$108K ﹤0.01% 1375
2022
Q1
$5.16M Sell
424,422
-5,120
-1% -$62.2K ﹤0.01% 1339
2021
Q4
$14.7M Sell
429,542
-8,554
-2% -$292K 0.01% 995
2021
Q3
$21.1M Sell
438,096
-10,305
-2% -$497K 0.01% 848
2021
Q2
$20.3M Sell
448,401
-11,840
-3% -$535K 0.01% 882
2021
Q1
$22.2M Buy
460,241
+5,169
+1% +$249K 0.01% 833
2020
Q4
$24.5M Sell
455,072
-12,890
-3% -$694K 0.01% 792
2020
Q3
$17.3M Buy
467,962
+2,458
+0.5% +$90.7K 0.01% 813
2020
Q2
$14.4M Buy
465,504
+18,256
+4% +$566K 0.01% 828
2020
Q1
$12.3M Buy
447,248
+350,722
+363% +$9.68M 0.01% 808
2019
Q4
$2.82M Buy
96,526
+3,790
+4% +$111K ﹤0.01% 1449
2019
Q3
$1.77M Buy
92,736
+19,510
+27% +$373K ﹤0.01% 1666
2019
Q2
$1.61M Buy
73,226
+8,549
+13% +$188K ﹤0.01% 1690
2019
Q1
$1.32M Buy
64,677
+8,098
+14% +$166K ﹤0.01% 1706
2018
Q4
$713K Buy
56,579
+32,679
+137% +$412K ﹤0.01% 1865
2018
Q3
$367K Hold
23,900
﹤0.01% 2211
2018
Q2
$313K Buy
+23,900
New +$313K ﹤0.01% 2280
2016
Q4
Sell
-25,600
Closed -$210K 2601
2016
Q3
$210K Hold
25,600
﹤0.01% 2440
2016
Q2
$206K Buy
+25,600
New +$206K ﹤0.01% 2429